Global dermatological cosmetic brand tHermoCEUTICAL successfully participated in the IMCAS World Congress 2025, held from January 30 to February 1 at the Palais des Congrès de Paris. tHermoCEUTICAL conducted over 120 B2B meetings with companies from 27 countries, fostering meaningful discussions on future business expansion and strengthening its global market presence.

A key highlight was a presentation by Prof. Dr. Uwe Paasch from Leipzig University, who introduced groundbreaking research on the basal membrane regeneration effects of tHermoCEUTICAL's flagship skin booster, ECMV RA. Additionally, Dr. Minjeong Kim, a Representative Doctor of Mihana Clinic in Korea, shared practical applications of ECMV RA, demonstrating its real-world efficacy. This successful participation reinforced tHermoCEUTICAL’s position as a leader in innovative skincare solutions and laid the foundation for continued global growth.​